cancer diagnostics tests that can be done cause of Nanomedicine - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

cancer diagnostics tests that can be done cause of Nanomedicine

Description:

Nanomedicine is an application of nanotechnology that deals in the prevention & treatment of diseases in humans. This technology uses submicrometer-sized particles for diagnosis, treatment, and prevention of diseases. Nanomedicines are advantageous over generic drugs in several aspects such as, to reduce renal excretion, improve the ability of drugs to accumulate at pathological sites, and enhance the therapeutic index of drugs. Thus, nanomedicine is used in a wide range of applications that include aerospace materials, cosmetics, and medicine. Get PDF Sample for Details @ – PowerPoint PPT presentation

Number of Views:9

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: cancer diagnostics tests that can be done cause of Nanomedicine


1
Opportunity Analysis and Industry Forecast,
2016-2023
Nanomedicine Market Expected to Reach 261,063
Million by 2023
2
Market Segmentation
By Application Drug Delivery Vaccines Diagnostic
Imaging Regenerative Medicine
By Modality Diagnostics Treatments
By Indication Oncological Diseases Infectious
Diseases Cardiovascular Diseases Orthopedic
Disorders Neurological Diseases Urological
Diseases
3
Nanomedicine Actual Market Value
  1. Global Nanomedicine Market accounted for 111,912
    million in 2016, and is anticipated to reach
    261,063 million by 2023, registering a CAGR of
    12.6 from 2017 to 2023.
  2. Nanomedicine is one of the applications of
    nanotechnology used in diagnosis, treatment,
    monitoring, and control of biological systems.
    Nanomedicine uses nanoscale manipulation of
    materials to improve medicine delivery.

4
Key Findings of Nanomedicine Market
The regenerative medicine segment is anticipated
to grow at the highest CAGR of 13.8 during the
forecast period.
China occupied one-third share of the
Asia-Pacific nanomedicine market in 2016,
registering a CAGR of 14.3 from 2017 to 2023.
The U.S. was the major shareholder in
the North America nanomedicine market in
2016.
5
Make An Inquiry About Report
https//www.alliedmarketresearch.com/purchase-enq
uiry/2021
 Get PDF Sample of Advance Research _at_
https//www.alliedmarketresearch.com/request-sampl
e/2021
6
Thank You! For More Details
Visit us at
https//www.alliedmarketresearch.com/nanomedicine-
market
SUBSCRIBE CHANNEL
FOLLOW US
About PowerShow.com